Please find enclosed the Monitoring Agency Report for the quarter ended June 30, 2026

Date: August 14, 2026 To To National Stock Exchange of India Ltd BSE Limited Exchange Plaza, 5th Floor, C-1, Block G, 1st Floor, Phiroze Jeejeebhoy Towers Dalal Street Bandra Kurla Complex, Bandra (E), Mumbai Mumbai – 400001 400051 Scrip Code: 544485 Symbol: REGAAL Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Dear Sir/ Madam, Pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we hereby submit the Monitoring Agency Report issued by CARE Ratings Limited, for the quarter ended June 30, 2026, in respect of utilization of gross proceeds of the IPO of the Company. This Monitoring agency report will also be available on the website of the Company at https://regaalresources.com/. Kindly take the above information on record. Thanking you, For Regaal Resources Limited Tinku Kumar Gupta Company Secretary and Compliance Officer No. CARE/KRO/GEN/2026-27/1068 The Board of Directors Regaal Resources Limited D2/2, Block- EP&GP, Sector V, Salt Lake Kolkata - 700091 August 14, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the IPO of Regaal Resources Limited We write in our capacity of Monitoring Agency for the IPO Issue for the amount aggregating to Rs.209.99 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 06, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Kamal Mahipal Associate Director Kamal.mahipal@careedge.in Report of the Monitoring Agency Name of the issuer: Regaal Resources Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Kamal Mahipal Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Regaal Resources Limited Name of the promoter : Anil Kishorepuria Industry/sector to which it belongs : Other Agricultural Products 2) Issue Details Issue Period : 08/12/2025 to 08/14/2025 Type of issue (public/rights) : Public issue (IPO) Type of specified securities : Equity shares IPO Grading, if any : Not Applicable Issue size (in crore) : Rs.306 crore (CARE Ratings Limited is monitoring only the gross proceeds pertaining to fresh issue under IPO amounting to Rs. 209.99 crore). 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments of Source of information / certifications Comments of the the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of preparation of report Directors The unutilized amount of issue No comment expense to the extent of Rs.0.59 Whether all utilization is as per the disclosures in the Offer Management certificate, CA certificate* No crore has been utilized towards Document? and Prospectus GCP as per Board Approval dated November 12, 2025. Whether shareholder approval has been obtained in case No comment of material deviations# from expenditures disclosed in the Management certificate Nil Applicable Offer Document? Whether the means of finance for the disclosed objects of No comment No Management certificate Nil the issue have changed? Is there any major deviation observed over the earlier Previous MA report for the quarter There was an over-utilization No comment monitoring agency reports? ended March 31, 2026, dated May 15, towards GCP by Rs.0.06 crore CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Comments of Source of information / certifications Comments of the the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of preparation of report Directors 2026, and Management certificate which was funded out of funds which were available for issue expenses. However, the company has now shared a Board Resolution dated November 12, 2025 as per which the unutilized amount of issue expense to the extent of Rs.0.59 crore shall be utilized towards GCP. Whether all Government/statutory approvals related to the Not No comment Management certificate Nil object(s) have been obtained? Applicable Whether all arrangements pertaining to technical No comment NA Management certificate Nil assistance/collaboration are in operation? Are there any favorable/unfavorable events affecting the No comment No Management certificate Nil viability of these object(s)? Is there any other relevant information that may materially No comment No Management certificate Nil affect the decision making of the investors? #Where material deviation may be defined to mean: a) Deviation in the objects or purposes for which the funds have been raised b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents. *As per internal auditor certificate from KASG & Co dated August 10, 2026. Note: We have received only management certificate certifying the above points. However, CA certificate does not certify the above points except for point 1. 4) Details of objects to be monitored: (i) Cost of objects – CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, S [Showing first 8,000 characters — download PDF for full document]